78 related articles for article (PubMed ID: 10022546)
1. Upregulation of fibrinolysis by adenovirus-mediated transfer of urokinase-type plasminogen activator genes to lung cells in vitro and in vivo.
Hattori N; Sisson TH; Xu Y; Simon RH
Hum Gene Ther; 1999 Jan; 10(2):215-22. PubMed ID: 10022546
[TBL] [Abstract][Full Text] [Related]
2. Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung.
Hattori N; Sisson TH; Xu Y; Desai TJ; Simon RH
Am J Physiol; 1999 Sep; 277(3):L573-9. PubMed ID: 10484465
[TBL] [Abstract][Full Text] [Related]
3. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes.
Sisson TH; Hattori N; Xu Y; Simon RH
Hum Gene Ther; 1999 Sep; 10(14):2315-23. PubMed ID: 10515451
[TBL] [Abstract][Full Text] [Related]
4. Adenovirally mediated gene transfer of functional human tissue-type plasminogen activator to murine lungs.
Simmons WL; Rivera KE; Curiel DT; Williams WF; Olman MA
Am J Respir Cell Mol Biol; 1998 Mar; 18(3):307-14. PubMed ID: 9490648
[TBL] [Abstract][Full Text] [Related]
5. Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury.
Marudamuthu AS; Bhandary YP; Shetty SK; Fu J; Sathish V; Prakash Y; Shetty S
Am J Pathol; 2015 Jan; 185(1):55-68. PubMed ID: 25447049
[TBL] [Abstract][Full Text] [Related]
6. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
7. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
8. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.
Olman MA; Mackman N; Gladson CL; Moser KM; Loskutoff DJ
J Clin Invest; 1995 Sep; 96(3):1621-30. PubMed ID: 7544811
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
[TBL] [Abstract][Full Text] [Related]
10. Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease.
Seth D; Hogg PJ; Gorrell MD; McCaughan GW; Haber PS
J Hepatol; 2008 Apr; 48(4):614-27. PubMed ID: 18289715
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis.
Bai X; Weitz JI; Gross PL
Thromb Haemost; 2009 Dec; 102(6):1212-8. PubMed ID: 19967153
[TBL] [Abstract][Full Text] [Related]
12. Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro.
Van Leer C; Stutz M; Haeberli A; Geiser T
Thromb Haemost; 2005 Dec; 94(6):1257-64. PubMed ID: 16411403
[TBL] [Abstract][Full Text] [Related]
13. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
14. Transgenic tissue-type plasminogen activator expression improves host defense during Klebsiella pneumonia.
Renckens R; Roelofs JJ; Stegenga ME; Florquin S; Levi M; Carmeliet P; Van't Veer C; van der Poll T
J Thromb Haemost; 2008 Apr; 6(4):660-8. PubMed ID: 18194423
[TBL] [Abstract][Full Text] [Related]
15. Localization of plasminogen activator activity within normal and injured lungs by in situ zymography.
Nishiuma T; Sisson TH; Subbotina N; Simon RH
Am J Respir Cell Mol Biol; 2004 Nov; 31(5):552-8. PubMed ID: 15284078
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.
Barazzone C; Belin D; Piguet PF; Vassalli JD; Sappino AP
J Clin Invest; 1996 Dec; 98(12):2666-73. PubMed ID: 8981909
[TBL] [Abstract][Full Text] [Related]
17. Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*.
Kager LM; Wiersinga WJ; Roelofs JJ; Meijers JC; Levi M; Van't Veer C; van der Poll T
Crit Care Med; 2012 Jul; 40(7):2168-75. PubMed ID: 22564963
[TBL] [Abstract][Full Text] [Related]
18. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
19. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.
Viscardi RM; Broderick K; Sun CC; Yale-Loehr AJ; Hessamfar A; Taciak V; Burke KC; Koenig KB; Idell S
Am Rev Respir Dis; 1992 Aug; 146(2):492-9. PubMed ID: 1489146
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines.
Lakka SS; Rajagopal R; Rajan MK; Mohan PM; Adachi Y; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Roth JA; Yung WK; Kyritsis AP; Rao JS
Clin Cancer Res; 2001 Apr; 7(4):1087-93. PubMed ID: 11309361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
